ArticleMicrobiologyOpen2026
Genome-Wide In Silico Analysis of the Type VI Secretion System (T6SS) Within the Morganella Genus.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Morganella spp., part of the Morganellaceae family, are opportunistic pathogens commonly found in the human gut microbiota. They are highly adaptable, cause various types of infections, and are difficult to treat due to virulence factors and resistance genes. In 2017, Morganella became part of the WHO Bacterial Pathogen Priority List (BPPL). In 2024, a genomic study revealed significant differences between clinically relevant species, particularly between M. sibonii and M. morganii, with M. sibonii possessing a unique type VI secretion system (T6SS) operon. This study aimed to explore the distribution and diversity of T6SS in Morganella species. A retrospective analysis of 293 Morganella genomes from 1966 to 2023 was conducted. The T6SS clusters and subtypes were annotated using the SecReT6 platform and RAST, with phylogenetic analysis performed on tssB genes. Putative effectors and immunity proteins were identified through in silico analysis using BlastP and Alphafold. We identified that M. sibonii isolates possess four T6SS clusters of subtypes i1, i3 v.1, i3 v.2, and i5. In contrast, most M. morganii isolates lacked T6SS, with only one-third containing a subtype i1 T6SS. Notably, M. morganii frequently (95%, 117/123 effectors) harbored a T6SS-predicted TseV effector, while M. sibonii exhibited a greater diversity of effectors. This study highlights species-specific T6SS patterns among Morganella genus and suggests that T6SS might play a crucial role in bacterial lifestyle competition and host-pathogen interactions. It paves the way for future research on Morganella pathogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.